$62.45+0.18 (+0.29%)
Pro-Dex, Inc.
Pro-Dex, Inc. in the Healthcare sector is trading at $62.45 with a market capitalization of $202M. Wall Street consensus targets $74.00 (1 analysts), implying a +18.5% move over the next 12 months. The stock is currently 19% below its 52-week high of $77.00, remaining 12.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $20.41Mβ | $19.95Mβ | $18.66Mβ | $18.53Mβ | $17.49M |
| Gross Profit | $7.09Mβ | $6.13Mβ | $5.74Mβ | $5.37Mβ | $3.49M |
| Operating Income | $3.53Mβ | $3.09Mβ | $3.26Mβ | $3.11Mβ | $1.34M |
| Net Income | $2.86Mβ | $3.94Mβ | $2.19Mβ | $4.68Mβ | $1.20M |
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shave...